相关实验视频
Updated: Jun 27, 2025

04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
366
老年人肥胖药物治疗:对证据的叙事性审查
Alex E Henney1,2,3, John P H Wilding4,5,6, Uazman Alam4,5,6
1Department of Cardiovascular & Metabolic Medicine, University of Liverpool, Liverpool, UK. alexander.henney@aintree.nhs.uk.
International journal of obesity (2005)
|May 6, 2024
概括
老年人中的肥胖率正在上升. 抗肥胖药物 (AOM) 显示出安全减肥和改善健康的前景,但需要对长期影响和身体成分进行更多研究.
科学领域:
- 老年学是一门学科.
- 肥胖医学 肥胖医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 60岁以上成年人肥胖率的上升带来了独特的挑战,平衡肥胖相关疾病的风险与减肥导致的肌肉和骨损失的担忧.
- "肥胖悖论"和与年龄相关的功能和认知能力下降使肥胖老年人的管理策略复杂化.
研究的目的:
- 审查当前的证据和抗肥胖药物 (AOM) 作为肥胖老年人体重管理的辅助疗法的作用.
- 突出这一群体中故意减肥的安全性和有效性,并确定当前研究中的差距.
主要方法:
- 对现有临床试验数据的审查,重点关注AOM,特别是老年人中的GLP-1受体激动剂 (利拉格卢提德,半氨酸,提泽帕提德) 等隐形蛋白疗法.
- 对AOMs对减肥,心脏代谢事件和身体组成 (骨肌肉和骨质) 的影响的分析.
主要成果:
- 在肥胖的老年人中,有意减肥越来越被认为是安全有效的.
- 目前在这个人口群体中的AOM研究是有限的,重点是基于incretin的疗法,这些疗法可以证明减肥和心脏代谢的好处,同时保持肌肉质量.
结论:
- 生活方式干预,包括抵抗训练,是老年人肥胖管理的基础.
- 使用AOM的药物治疗可以成为耐火病例的宝贵补充,但未来的试验必须评估长期有效性,体质组成,功能能力和经济影响.
相关概念视频
Obesity
468
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
468
Diabetes: Management and Pharmacotherapy
266
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
266
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Antidepressant Drugs: MAOIs and Other Agents
226
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
226
Drug Administration and Therapy Phases: Overview
451
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
451
Oral Hypoglycemic Agents: Biguanides and Glitazones
192
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
192

